Chronic prednisolone treatment reduces hepatic insulin sensitivity while perturbing the fed-to-fasting transition in mice

Endocrinology

Volumn 151, Issue 5, 2010, Pages 2171-2178

  Laskewitz, Anke J ^a   Van Dijk, Theo H ^a   Bloks, Vincent W ^a   Reijngoud, Dirk Jan ^a   Van Lierop, Marie José ^b   Dokter, Wim H ^b   Kuipers, Folkert ^a   Groen, Albert K ^a   Grefhorst, Aldo ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; FATTY ACID; FIBROBLAST GROWTH FACTOR 21; GLUCOSE; INSULIN; PREDNISOLONE; FIBROBLAST GROWTH FACTOR; GLUCOCORTICOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; ENERGY METABOLISM; FATTY ACID BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIVER; LONG TERM CARE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ALGORITHM; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECT; EATING; GENE EXPRESSION; GENETICS; GLUCOSE CLAMP TECHNIQUE; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY; TISSUE DISTRIBUTION;

ALGORITHMS; ANIMALS; BLOOD GLUCOSE; EATING; ENERGY METABOLISM; FASTING; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; GLUCOCORTICOIDS; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; INSULIN; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; PPAR ALPHA; PREDNISOLONE; TISSUE DISTRIBUTION;

EID: 77953170019     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1374     Document Type: Article

References (38)

1. Schacke H, Docke W, Asadullah K 2002 Mechanisms involved in the side effects of glucocorticoids. Pharmacol Therapeut 96:23-43 (Pubitemid 35346616)
2. Schoneveld OJ, Gaemers IC, Lamers WH 2004 Mechanisms of glucocorticoid signalling. Biochim Biophys Acta 1680:114-128
3. Giguère V, Hollenberg SM, Rosenfeld MG, Evans RM 1986 Functional domains of the human glucocorticoid receptor. Cell 46:645-652
4. Stanbury RM, Graham EM 1998 Systemic corticosteroid therapy - side effects and their management. Br J Ophthalmol 82:704-708 (Pubitemid 28306665)
5. Walker BR 2006 Cortisol - cause and cure for metabolic syndrome? Diabet Med 23:1281-1288
6. Dessein PH, Joffe BI, Stanwix AE, Christian BF, Veller M 2004 Glucocorticoids and insulin sensitivity in rheumatoid arthritis. J Rheumatol 31:867-874 (Pubitemid 38585808)
7. Bowes SB, Benn JJ, Scobie IN, Umpleby AM, Lowy C, Sonksen PH 1991 Glucose metabolism in patients with Cushing's syndrome. Clin Endocrinol 34:311-316
8. Nicod N, Giusti V, Besse C, Tappy L 2003 Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers. Obes Res 11:625-631
9. Pagano G, Cavallo-Perin P, Cassader M, Bruno A, Ozzello A, Masciola P, Dall'omo AM, Imbimbo B 1983 An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest 72:1814-1820
10. Tappy L, Randin D, Vollenweider P, Vollenweider L, Paquot N, Scherrer U, Schneiter P, Nicod P, Jéquier E 1994 Mechanisms of dexamethasone-induced insulin resistance in healthy humans. J Clin Endocrinol Metab 79:1063-1069
11. Rizza RA, Mandarino LJ, Gerich JE 1982 Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab 54:131-138
12. Binnert C, Ruchat S, Nicod N, Tappy L 2004 Dexamethasone-induced insulin resistance shows no gender difference in healthy humans. Diabetes Metab 30:321-326 (Pubitemid 39280230)
13. Friedman JE, Yun JS, Patel YM, McGrane MM, Hanson RW 1993 Glucocorticoids regulate the induction of phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes. J Biol Chem 268:12952-12957
14. Saad MJ, Folli F, Kahn JA, Kahn CR 1993 Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J Clin Invest 92:2065-2072
15. Stojanovska L, Rosella G, Proietto J 1990 Evolution of dexamethasone- induced insulin resistance in rats. Am J Physiol 258:E748-E756
16. Guillaume-Gentil C, Assimacopoulos-Jeannet F, Jeanrenaud B 1993 Involvement of non-esterified fatty acid oxidation in glucocorticoid- induced peripheral insulin resistance in vivo in rats. Diabetologia 36:899-906
17. Bernal-Mizrachi C, Weng S, Feng C, Finck BN, Knutsen RH, Leone TC, Coleman T, Mecham RP, Kelly DP, Semenkovich CF 2003 Dexamethasone induction of hypertension and diabetes is PPAR-α dependent in LDL receptor-null mice. Nat Med 9:1069-1075
18. Gounarides JS, Korach-André M, Killary K, Argentieri G, Turner O, Laurent D 2008 Effect of dexamethasone on glucose tolerance and fat metabolism in a diet-induced obesity mouse model. Endocrinology 149:758-766
19. Thomas CR, Turner SL, Jefferson WH, Bailey CJ 1998 Prevention of dexamethasone-induced insulin resistance by metformin. Biochem Pharmacol 56:1145-1150
20. Grefhorst A, van Dijk TH, Hammer A, van der Sluijs FH, Havinga R, Havekes LM, Romijn JA, Groot PH, Reijngoud DJ, Kuipers F 2005 Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice. Am J Physiol Endocrinol Metab 289:E829-E838
21. Kuipers F, Havinga R, Bosschieter H, Toorop GP, Hindriks FR, Vonk RJ 1985 Enterohepatic circulation in the rat. Gastroenterology 88:403-411
22. Bligh EG, Dyer WJ 1959 A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917
23. Keppler D, Decker K 1970 Glykogen. Bestimmung mit amyloglucosidase. In: Bergmeyer HU, ed. Methoden der Enzymatischen Analyse. Weinheim, Germany: Verlag Chemie; 1089-1094
24. van Dijk TH, Boer TS, Havinga R, Stellaard F, Kuipers F, Reijngoud DJ 2003 Quantification of hepatic carbohydrate metabolism in conscious mice using serial blood and urine spots. Anal Biochem 322:1-13
25. Lee WN, Byerley LO, Bergner EA, Edmond J 1991 Mass isotopomer analysis: theoretical and practical considerations. Biol Mass Spectrom 20:451-458
26. -/- mice. J Biol Chem 284:10315-10323
27. Stricker D 2008 BrightStat.com: free statistics online. Comput Meth Prog Bio 92:135-143
28. Brattsand R, Thalén A, Roempke K, Källström L, Gruvstad E 1982 Influence of 16α, 17α-acetal substitution and steroid nucleus fluorination on the topical to systemic activity ratio of glucocorticoids. J Steroid Biochem 16:779-786
29. Compton MM, Cidlowski JA 1986 Rapid in vivo effects of glucocorticoids on the integrity of rat lymphocyte genomic deoxyribonucleic acid. Endocrinology 118:38-45
30. Beato M, Chalepakis G, Schauer M, Slater EP 1989 DNA regulatory elements for steroid hormones. J Steroid Biochem 32:737-747
31. Balsalobre A, Brown SA, Marcacci L, Tronche F, Kellendonk C, Reichardt HM, Schütz G, Schibler U 2000 Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 289: 2344-2347
32. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W 1999 Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. J Clin Invest 103:1489-1498
33. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, Gromada J, Brozinick JT, Hawkins ED, Wroblewski VJ, Li DS, Mehrbod F, Jaskunas SR, Shanafelt AB 2005 FGF-21 as a novel metabolic regulator. J Clin Invest 115:1627-1635
34. Hotta Y, Nakamura H, Konishi M, Murata Y, Takagi H, Matsumura S, Inoue K, Fushiki T, Itoh N 2009 Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Endocrinology 150:4625-4633
35. Bougarne N, Paumelle R, Caron S, Hennuyer N, Mansouri R, Gervois P, Staels B, Haegeman G, De Bosscher K 2009 PPARα blocks glucocorticoid receptor α-mediated transactivation but cooperates with the activated glucocorticoid receptor α for transrepression on NF-κB. Proc Natl Acad Sci USA 106:7397-7402
36. Jin JY, DuBois DC, Almon RR, Jusko WJ 2004 Receptor/gene-mediated pharmacodynamic effects of methylprednisolone on phosphoenolpyruvate carboxykinase regulation in rat liver. J Pharmacol Exp Ther 309:328-339
37. Hashida N, Ohguro N, Arakawa Y, Kurokawa N, Tano Y 2006 Intraocular concentration of intravenous prednisolone in experimental autoimmune uveoretinitis mice. Jpn J Ophthalmol 50:561-562
38. Hegarty BD, Bobard A, Hainault I, Ferré P, Bossard P, Foufelle F 2005 Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c. Proc Natl Acad Sci USA 102:791-796 (Pubitemid 40282744)